Jang Y - Search Results

1

Optimal duration of DAPT after second-generation drug-eluting stent in acute coronary syndrome.

Jang JY, Shin DH, Kim JS, Hong SJ, Ahn CM, Kim BK, Ko YG, Choi D, Hong MK, Park KW, Gwon HC, Kim HS, Jang Y. Jang JY, et al. Among authors: jang y. PLoS One. 2018 Nov 26;13(11):e0207386. doi: 10.1371/journal.pone.0207386. eCollection 2018. PLoS One. 2018. PMID: 30475845 Free PMC article. Clinical Trial.

2

Comparison of gold-coated NIR stents with uncoated NIR stents in patients with coronary artery disease.

Park SJ, Lee CW, Hong MK, Kim JJ, Park SW, Tahk SJ, Jang YS, Seung KB, Yang JY, Jeong MH. Park SJ, et al. Am J Cardiol. 2002 Apr 1;89(7):872-5. doi: 10.1016/s0002-9149(02)02206-3. Am J Cardiol. 2002. PMID: 11909580 Clinical Trial. No abstract available.

3

Fate of collateral circulation after successful coronary angioplasty of total occlusion assessed by coronary angiography and myocardial contrast echocardiography.

Ha JW, Cho SY, Chung N, Choi DH, Choi BJ, Jang Y, Shim WH, Kim SS. Ha JW, et al. Among authors: jang y. J Am Soc Echocardiogr. 2002 May;15(5):389-95. doi: 10.1067/mje.2002.115185. J Am Soc Echocardiogr. 2002. PMID: 12019421

4

Stent-graft placement for femoral artery pseudoaneurysm in a patient with idiopathic multiple arterial aneurysmal disease.

Koo BK, Choi D, Kwon K, Jang Y, Shim WH, Cho SY, Lee DY. Koo BK, et al. Among authors: jang y. Cardiovasc Intervent Radiol. 2002 Nov-Dec;25(6):520-3. doi: 10.1007/s00270-001-0107-6. Cardiovasc Intervent Radiol. 2002. PMID: 12357311

5

Percutaneous stent-graft repair of mycotic common femoral artery aneurysm.

Kwon K, Choi D, Choi SH, Koo BK, Ko YG, Jang Y, Shim WH, Cho SY. Kwon K, et al. Among authors: jang y. J Endovasc Ther. 2002 Oct;9(5):690-3. doi: 10.1177/152660280200900522. J Endovasc Ther. 2002. PMID: 12431156

6

Relation of vasodilator response of the brachial artery to inflammatory markers in patients with coronary artery disease.

Kang SM, Chung N, Kim JY, Koo BK, Choi D, Jang Y, Cho SY. Kang SM, et al. Among authors: jang y. Echocardiography. 2002 Nov;19(8):661-7. doi: 10.1046/j.1540-8175.2002.00661.x. Echocardiography. 2002. PMID: 12487635

7

Long-term (three-year) outcomes after stenting of unprotected left main coronary artery stenosis in patients with normal left ventricular function.

Park SJ, Park SW, Hong MK, Lee CW, Lee JH, Kim JJ, Jang YS, Shin EK, Yoshida Y, Tamura T, Kimura T, Nobuyoshi M. Park SJ, et al. Among authors: jang ys. Am J Cardiol. 2003 Jan 1;91(1):12-6. doi: 10.1016/s0002-9149(02)02990-9. Am J Cardiol. 2003. PMID: 12505564

8

Catheter-based adenovirus-mediated local intravascular gene delivery of a soluble TGF-beta type II receptor using an infiltrator in porcine coronary arteries: efficacy and complications.

Chung IM, Ueno H, Pak YK, Kim JW, Choi DH, Shin GJ, Yang WI, Jang Ys. Chung IM, et al. Exp Mol Med. 2002 Sep 30;34(4):299-307. doi: 10.1038/emm.2002.42. Exp Mol Med. 2002. PMID: 12515396

9

Treatment of thoracic aortic dissection with stent-grafts: midterm results.

Shim WH, Koo BK, Yoon YS, Choi D, Jang Y, Lee DY, Chang BC. Shim WH, et al. Among authors: jang y. J Endovasc Ther. 2002 Dec;9(6):817-21. doi: 10.1177/152660280200900615. J Endovasc Ther. 2002. PMID: 12546583

10

Calreticulin inhibits the MEK1,2-ERK1,2 pathway in alpha 1-adrenergic receptor/Gh-stimulated hypertrophy of neonatal rat cardiomyocytes.

Lee KH, Lee N, Lim S, Jung H, Ko YG, Park HY, Jang Y, Lee H, Hwang KC. Lee KH, et al. Among authors: jang y. J Steroid Biochem Mol Biol. 2003 Jan;84(1):101-7. doi: 10.1016/s0960-0760(03)00006-2. J Steroid Biochem Mol Biol. 2003. PMID: 12648529

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,720 results

Search Page

Filters